Zepp Health Projects Q2 Revenue Between $63M and $68M
ZEPP has more than doubled off its 52-week low of $2.25 on elevated volume (2.3× avg).
Summary
Zepp Health has issued Q2 revenue guidance, projecting sales between $63.0 million and $68.0 million. This forward-looking statement is highly material for a company of this size, providing a crucial update on expected performance. This guidance follows the company's strong Q4 and full year 2025 results, which were reported in March and April.
At the time of this announcement, ZEPP was trading at $6.34 on NYSE in the Technology sector, with a market capitalization of approximately $90.9M. The 52-week trading range was $2.25 to $61.85. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.